Should I buy or sell LivaNova stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LivaNova in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" LIVN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LIVN, but not buy additional shares or sell existing shares. View LIVN analyst ratings or view top-rated stocks .

What is LivaNova's stock price target for 2024?

5 brokerages have issued 1 year target prices for LivaNova's stock. Their LIVN share price targets range from $52.00 to $75.00. On average, they anticipate the company's stock price to reach $64.40 in the next twelve months. This suggests a possible upside of 22.1% from the stock's current price. View analysts price targets for LIVN or view top-rated stocks among Wall Street analysts .

How have LIVN shares performed in 2024?

LivaNova's stock was trading at $51.74 at the beginning of the year. Since then, LIVN stock has increased by 2.0% and is now trading at $52.76. View the best growth stocks for 2024 here .

When is LivaNova's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our LIVN earnings forecast .

How can I listen to LivaNova's earnings call?

LivaNova will be holding an earnings conference call on Wednesday, May 1st at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link .

How were LivaNova's earnings last quarter?

LivaNova PLC (NASDAQ:LIVN) released its earnings results on Wednesday, February, 21st. The company reported $0.87 EPS for the quarter, beating the consensus estimate of $0.77 by $0.10. The firm had revenue of $310.10 million for the quarter, compared to the consensus estimate of $287.65 million. LivaNova had a trailing twelve-month return on equity of 12.23% and a net margin of 1.53%. LivaNova's revenue was up 12.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.81 earnings per share.

What ETFs hold LivaNova's stock?

ETFs with the largest weight of LivaNova (NASDAQ:LIVN) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE) , IQ Healthy Hearts ETF (HART) , Simplify Health Care ETF (PINK) and Invesco S&P MidCap 400 GARP ETF (EWMC) . iShares U.S. Medical Devices ETF (IHI) .

What guidance has LivaNova issued on next quarter's earnings?

LivaNova issued an update on its FY24 earnings guidance on Wednesday, February, 21st. The company provided EPS guidance of $2.95-3.05 for the period, compared to the consensus EPS estimate of $2.99.

What is Damien McDonald's approval rating as LivaNova's CEO?

47 employees have rated LivaNova Chief Executive Officer Damien McDonald on Glassdoor.com . Damien McDonald has an approval rating of 77% among the company's employees.

What other stocks do shareholders of LivaNova own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LivaNova investors own include BioTelemetry (BEAT) , Occidental Petroleum (OXY) , Pfizer (PFE) , Amarin (AMRN) , Genocea Biosciences (GNCA) , AbbVie (ABBV) , Abbott Laboratories (ABT) , ACADIA Pharmaceuticals (ACAD) , Chipotle Mexican Grill (CMG) and CRISPR Therapeutics (CRSP) .

Who are LivaNova's major shareholders?

LivaNova's stock is owned by a variety of institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (1.46%), Perpetual Ltd (0.41%), State of Michigan Retirement System (0.02%) and Diversified Trust Co (0.02%). Insiders that own company stock include Alfred J Novak , Damien Mcdonald , Daniel Jeffrey Moore and Marco Dolci . View institutional ownership trends .

How do I buy shares of LivaNova?

Shares of LIVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:LIVN

LivaNova (LIVN) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free LIVN Stock Alerts

$52.76

+0.89 (+1.72%)

(As of 04/18/2024 ET)

Compare

Today's Range: $51.71
▼
$52.89
50-Day Range: $48.75
▼
$57.12
52-Week Range: $42.75
▼
$59.86

Volume: 537,422 shs
Average Volume: 558,805 shs
Market Capitalization: $2.85 billion

P/E Ratio: 164.88
Dividend Yield: N/A
Price Target: $64.40

Get LivaNova alerts:

LivaNova MarketRank™ Stock Analysis

Analyst Rating: Hold
2.40 Rating Score
Upside/Downside: 22.1% Upside
$64.40 Price Target
Short Interest: Healthy
6.13% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: -0.42
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 11.30%
From $3.01 to $3.35 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.26 out of 5 stars

Medical Sector

745th out of 918 stocks

Electromedical Equipment Industry

14th out of 20 stocks

2.2

Analyst's Opinion

Consensus Rating
LivaNova has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.
Amount of Analyst Coverage
LivaNova has only been the subject of 4 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
6.13% of the outstanding shares of LivaNova have been sold short.
Short Interest Ratio / Days to Cover
LivaNova has a short interest ratio ("days to cover") of 5.3.
Change versus previous month
Short interest in LivaNova has recently decreased by 5.16%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
LivaNova does not currently pay a dividend.
Dividend Growth
LivaNova does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for LIVN.

0.9

News and Social Media Coverage

News Sentiment
LivaNova has a news sentiment score of -0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for LivaNova this week, compared to 3 articles on an average week.
Search Interest
Only 1 people have searched for LIVN on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added LivaNova to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, LivaNova insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.19% of the stock of LivaNova is held by insiders.
Percentage Held by Institutions
97.64% of the stock of LivaNova is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for LivaNova are expected to grow by 11.30% in the coming year, from $3.01 to $3.35 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of LivaNova is 164.88, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 136.92.
Price to Earnings Ratio vs. Sector
The P/E ratio of LivaNova is 164.88, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 191.64.
Price to Book Value per Share Ratio
LivaNova has a P/B Ratio of 2.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About LivaNova Stock (NASDAQ:LIVN)

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

LIVN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

LIVN Stock News Headlines

April 18, 2024 | americanbankingnews.com

LivaNova (NASDAQ:LIVN) Downgraded by StockNews.com to "Hold"

April 15, 2024 | finance.yahoo.com

Shareholders in LivaNova (NASDAQ:LIVN) have lost 34%, as stock drops 3.1% this past week

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 10, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and LivaNova (LIVN)

March 23, 2024 | wsj.com

LivaNova PLC

March 22, 2024 | uk.finance.yahoo.com

LivaNova to Announce First-Quarter 2024 Results

March 21, 2024 | marketwatch.com

LivaNova Shares Gain 12% After Reporting High Likelihood of Trial Meeting Endpoint

March 20, 2024 | msn.com

LivaNova gains after positive predictive outcome of sleep apnea study

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

March 19, 2024 | finance.yahoo.com

Returns On Capital Signal Difficult Times Ahead For LivaNova (NASDAQ:LIVN)

March 6, 2024 | investing.com

LivaNova plans $300 million convertible note offering

March 5, 2024 | businesswire.com

LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029

March 4, 2024 | businesswire.com

LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes

February 28, 2024 | finance.yahoo.com

LIVN Jan 2025 52.500 put

February 26, 2024 | markets.businessinsider.com

LivaNova: Balancing Act Between Operational Strengths and Market Realignment Justifies Hold Rating

February 25, 2024 | msn.com

LivaNova (LIVN) Price Target Increased by 8.89% to 68.00

February 23, 2024 | msn.com

Mizuho Upgrades LivaNova (LIVN)

February 23, 2024 | finance.yahoo.com

Has LivaNova PLC's (NASDAQ:LIVN) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

February 21, 2024 | markets.businessinsider.com

Walmart To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday

February 21, 2024 | finance.yahoo.com

LivaNova (LIVN) Q4 Earnings and Revenues Top Estimates

February 21, 2024 | finanznachrichten.de

LivaNova PLC: LivaNova Reports Fourth-Quarter and Full-Year 2023 Results

February 21, 2024 | finance.yahoo.com

LivaNova Reports Fourth-Quarter and Full-Year 2023 Results

February 21, 2024 | markets.businessinsider.com

Here's what to expect from Livanova's earnings report

February 21, 2024 | msn.com

LivaNova PLC Non-GAAP EPS of $0.87 beats by $0.10, revenue of $310.1M beats by $22.4M

February 21, 2024 | finance.yahoo.com

LivaNova PLC (LIVN) Posts Double-Digit Revenue Growth in Q4 and Full-Year 2023

February 21, 2024 | seekingalpha.com

LivaNova PLC 2023 Q4 - Results - Earnings Call Presentation

February 21, 2024 | businesswire.com

LivaNova Reports Fourth-Quarter and Full-Year 2023 Results

See More Headlines

Receive LIVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/21/2024
Today: 4/18/2024
Next Earnings (Confirmed): 5/01/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: NASDAQ:LIVN
CUSIP: N/A
CIK: 1639691
Web: www.livanova.com
Phone: 442033250660
Fax: 281-218-9332
Employees: 2,900
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $64.40
High Stock Price Target: $75.00
Low Stock Price Target: $52.00
Potential Upside/Downside: +22.1%
Consensus Rating: Hold
Rating Score (0-4): 2.40
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.32
Trailing P/E Ratio: 164.88
Forward P/E Ratio: 17.53
P/E Growth: N/A
Net Income: $17.55 million
Net Margins: 1.53%
Pretax Margin: -7.04%
Return on Equity: 12.23%
Return on Assets: 6.47%

Debt

Debt-to-Equity Ratio: 0.44
Current Ratio: 2.95
Quick Ratio: 2.51

Sales & Book Value

Annual Sales: $1.15 billion
Price / Sales: 2.47
Cash Flow: $4.27 per share
Price / Cash Flow: 12.35
Book Value: $23.72 per share
Price / Book: 2.22

Miscellaneous

Outstanding Shares: 53,960,000
Free Float: 53,853,000
Market Cap: $2.85 billion
Optionable: Optionable
Beta: 0.89

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Mr. Alex Shvartsburg (Age 53)
Chief Financial Officer
Comp: $852.2k
Ms. Trui Hebbelinck (Age 52)
Chief Human Resources Officer
Comp: $731.41k
Mr. Vladimir A. Makatsaria
CEO & Director
Mr. Badri Amurthur
Chief Technology Officer
Lindsey Little
Senior Director of Investor Relations
Mr. Michael D. Hutchinson (Age 53)
Senior VP, Chief Legal Officer & Company Secretary
Deanna Wilke
Vice President of Corporate Communications
Mr. Matthew Joseph Dodds III
Senior Vice President of Corporate Development & IT
Dr. Bryan D. Olin Ph.D. (Age 57)
Senior VP & Head of Product Development - Neuromodulation
Mr. Ryan Miller
President of Advanced Circulatory Support

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

LIVN Stock Analysis - Frequently Asked Questions

Should I buy or sell LivaNova stock right now?: 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LivaNova in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" LIVN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LIVN, but not buy additional shares or sell existing shares.
View LIVN analyst ratings or view top-rated stocks.
What is LivaNova's stock price target for 2024?: 5 brokerages have issued 1 year target prices for LivaNova's stock. Their LIVN share price targets range from $52.00 to $75.00. On average, they anticipate the company's stock price to reach $64.40 in the next twelve months. This suggests a possible upside of 22.1% from the stock's current price.
View analysts price targets for LIVN or view top-rated stocks among Wall Street analysts.
How have LIVN shares performed in 2024?: LivaNova's stock was trading at $51.74 at the beginning of the year. Since then, LIVN stock has increased by 2.0% and is now trading at $52.76.
View the best growth stocks for 2024 here.
When is LivaNova's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our LIVN earnings forecast.
How can I listen to LivaNova's earnings call?: LivaNova will be holding an earnings conference call on Wednesday, May 1st at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.
How were LivaNova's earnings last quarter?: LivaNova PLC (NASDAQ:LIVN) released its earnings results on Wednesday, February, 21st. The company reported $0.87 EPS for the quarter, beating the consensus estimate of $0.77 by $0.10. The firm had revenue of $310.10 million for the quarter, compared to the consensus estimate of $287.65 million. LivaNova had a trailing twelve-month return on equity of 12.23% and a net margin of 1.53%. LivaNova's revenue was up 12.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.81 earnings per share.

What ETFs hold LivaNova's stock?: ETFs with the largest weight of LivaNova (NASDAQ:LIVN) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), IQ Healthy Hearts ETF (HART), Simplify Health Care ETF (PINK) and Invesco S&P MidCap 400 GARP ETF (EWMC).iShares U.S. Medical Devices ETF (IHI).
What guidance has LivaNova issued on next quarter's earnings?: LivaNova issued an update on its FY24 earnings guidance on Wednesday, February, 21st. The company provided EPS guidance of $2.95-3.05 for the period, compared to the consensus EPS estimate of $2.99.
What is Damien McDonald's approval rating as LivaNova's CEO?: 47 employees have rated LivaNova Chief Executive Officer Damien McDonald on Glassdoor.com. Damien McDonald has an approval rating of 77% among the company's employees.
What other stocks do shareholders of LivaNova own?: Based on aggregate information from My MarketBeat watchlists, some companies that other LivaNova investors own include BioTelemetry (BEAT), Occidental Petroleum (OXY), Pfizer (PFE), Amarin (AMRN), Genocea Biosciences (GNCA), AbbVie (ABBV), Abbott Laboratories (ABT), ACADIA Pharmaceuticals (ACAD), Chipotle Mexican Grill (CMG) and CRISPR Therapeutics (CRSP).
Who are LivaNova's major shareholders?: LivaNova's stock is owned by a variety of institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (1.46%), Perpetual Ltd (0.41%), State of Michigan Retirement System (0.02%) and Diversified Trust Co (0.02%). Insiders that own company stock include Alfred J Novak, Damien Mcdonald, Daniel Jeffrey Moore and Marco Dolci.
View institutional ownership trends.
How do I buy shares of LivaNova?: Shares of LIVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LIVN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

LivaNova (LIVN) Stock Price, News & Analysis

LivaNova MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About LivaNova Stock (NASDAQ:LIVN)

LIVN Stock Price History

LIVN Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

LIVN Stock Analysis - Frequently Asked Questions

Overall MarketRank^™